AbbVie announces participation in TD Cowen's annual health care conference

AbbVie announces participation in TD Cowen's annual health care conference

Health Care
Webp 1au47zp4ura2kdpfj4n590wnfv86
Nicholas Donoghoe M.D. Executive Vice President, Chief Business and Strategy Officer | AbbVie

ORGANIZATIONS IN THIS STORY

LETTER TO THE EDITOR

Have a concern or an opinion about this story? Click below to share your thoughts.
Send a message

Community Newsmaker

Know of a story that needs to be covered? Pitch your story to The Business Daily.
Community Newsmaker

AbbVie is set to participate in the TD Cowen's 45th Annual Health Care Conference, scheduled for Wednesday, March 5, 2025. The company's management will engage in a fireside chat at 8:10 a.m. Central time.

The event will be accessible via a live audio webcast on AbbVie's Investor Relations website at investors.abbvie.com. An archived version of the session will be available later that day.

AbbVie focuses on discovering and delivering innovative medicines and solutions to address serious health issues and medical challenges. Their work spans key therapeutic areas such as immunology, oncology, neuroscience, and eye care, along with products in their Allergan Aesthetics portfolio.

For further details about AbbVie, visit www.abbvie.com or follow @abbvie on various social media platforms including LinkedIn, Facebook, Instagram, X (formerly Twitter), and YouTube.

For media inquiries contact Gabby Tarbert at (224) 244-0111 or gabrielle.tarbert@abbvie.com. Investors can reach out to Liz Shea at (847) 935-2211 or liz.shea@abbvie.com.

SOURCE AbbVie

ORGANIZATIONS IN THIS STORY

LETTER TO THE EDITOR

Have a concern or an opinion about this story? Click below to share your thoughts.
Send a message

Community Newsmaker

Know of a story that needs to be covered? Pitch your story to The Business Daily.
Community Newsmaker

MORE NEWS